Nordic Bone

ABOUT USINVESTORSPIPELINENEWSCAREERSCONTACT

Press Releases

November 10, 2008

Osteologix to Present Corporate Overview at Upcoming Conferences

Rodman and Renshaw Annual Global Investment Conference

BIO Europe 14th Annual International Partnering Conference

October 29, 2008

Osteologix to Present at 7th Annual BIO Investor Forum

Thursday October 30
Palace Hotel
San Francisco, CA

Osteologix to Present Corporate Overview and Phase 2 Osteoporosis Data at the BIO International Conference

2008 BIO International Convention

Osteologix to Present at the FBR Capital Markets 12th Annual Spring Investor Conference

Osteologix Presents Phase 2 Osteoporosis Data at a Major European Medical Conference

Journal Publication Highlights Bone Formation Activity of NB S101

Poster: Effect of 3 Doses of Strontium Malonate (NB S101) on Markers of Bone Turnover and Bone Mineral Density: The STRONG Study

Osteologix Presents Phase 2 Osteoporosis Data at a Major European Medical Conference

New Journal Publication Highlights Bone Formation Activity of NB S101

Osteologix to Present at the Rodman and Renshaw 5th Annual Global Healthcare Conference

Osteologix IND for NB S101 for Osteoporosis Accepted by FDA

Osteologix Completes $5.3 Million Private Placement Financing

Osteologix Enters Into $5.3 Million Private Placement Financing Agreement

February 6, 2008

Osteologix to Present at BIO CEO & Investor Conference

November 26, 2007

Osteologix to Present at Lazard Capital Markets 4th Annual Healthcare Conference

November 5, 2007

Osteologix Announces Positive Phase II Study of Its Investigational Osteoporosis Drug, NB S101

Trial Meets Primary Endpoint

November 1, 2007

Osteologix Executive to Present at 6th Annual Partnerships in Clinical Trials Congress and Exhibition 2007

October 30, 2007

Osteologix to Present at the Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference

October 24, 2007

Osteologix CEO to Present at Eye for Pharma Early Commercialization, Lifecycle and Portfolio Management Congress 2007

October 8, 2007

Osteologix to Present at BIO Investor Forum; Webcast: October 10, 2007

September 28, 2007

Osteologix to Present at NASDAQ MarketSite during EQUITIES 2007 Transatlantic Conference

September 19, 2007

Osteologix Presents Positive Osteoporosis Drug Data to International Audience of Physicians

Data Demonstrates the Improved Strontium Bioavailability of NB S101 to Strontium Ranelate